Effective May 12, 2022, New York State (NYS) Medicaid fee-for-service (FFS) and Medicaid managed care (MMC) plans [including Mainstream MMC Plans, Human Immunodeficiency Virus (HIV) Special Needs Plans (HIV-SNPs), and Health and Recovery Plans (HARPs)] will implement the following billing guidance for SPRAVATO® (esketamine) in the Medicaid program.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
